Live tape
Mentions 7d9,748MSFT1,756 mentions▲ +0.06GOOGL1,721 mentions▲ +0.03NFLX1,372 mentions+0.02NVDA1,193 mentions▲ +0.08QQQ1,053 mentions▲ +0.06SNDK933 mentions▲ +0.07META916 mentions▲ +0.04SPY804 mentions▲ +0.02
Equity · Healthcare

INDV

INDV · NasdaqGS
$40.55
−0.02% 1D
Price · Chart Chart by TradingView

Crowd sentiment on INDV · 30d

Method · 0 mentions
Bullish 0%
Neutral 100%
Bearish 0%

Across 0 classified mentions in the last 30 days, crowd sentiment for INDV sits roughly neutral, with 0% reading bullish against 0% bearish across the classified sample.

INDV insider trades

SEC Form 4
Date Insider Type Shares Value
10 Jul 2026 Heidbreder Christian Chief Scientific Officer SELL 18,586 $765K
22 Jun 2026 Ciaffoni Joseph Chief Executive Officer OPTION EXERCISE 1,266,903
22 Jun 2026 Ciaffoni Joseph Chief Executive Officer TAX WITHHOLD 612,549 $23.47M
11 Jun 2026 Heidbreder Christian Chief Scientific Officer SELL 18,586 $707K
08 Jun 2026 Preblick Ryan Chief Financial Officer SELL 36,000 $1.36M
13 May 2026 Humphreys Keith Director AWARD 6,518
13 May 2026 NINIVAGGI DANIEL A Director AWARD 6,518
13 May 2026 Kingsley Stuart A Director AWARD 6,518

INDV earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $0.69 $317M
31 Dec 2025 FY 2025 $1.64 $1.24B
30 Sep 2025 Q3 2025 $0.33 $314M
30 Jun 2025 Q2 2025 $0.14 $302M

Reported figures & scheduled dates · SEC EDGAR filings